Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A New Series of Schiff Base Derivatives Bearing 1,2,3-Triazole: Design, Synthesis, Molecular Docking, and Α-Glucosidase Inhibition Publisher Pubmed



Nasliesfahani E1 ; Mohammadikhanaposhtani M2 ; Rezaei S3 ; Sarrafi Y4 ; Sharafi Z5 ; Samadi N6 ; Faramarzi MA6 ; Bandarian F1 ; Hamedifar H7 ; Larijani B8 ; Hajimiri M9 ; Mahdavi M8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  3. 3. School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Faculty of Chemistry, University of Mazandaran, Babolsar, Iran
  5. 5. Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  6. 6. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
  8. 8. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Nano Alvand Company, Avicenna Tech Park, Tehran University of Medical Sciences, Tehran, Iran

Source: Archiv der Pharmazie Published:2019


Abstract

A series of new Schiff bases bearing 1,2,3-triazole 12a‒o was designed, synthesized, and evaluated as α-glucosidase inhibitors. All the synthesized compounds showed promising inhibition against α-glucosidase and were more potent than the standard drug acarbose. The kinetic study on the most potent compound 12n showed that this compound acted as a competitive α-glucosidase inhibitor. The docking study revealed that the synthesized compounds interacted with the important residues in the active site of α-glucosidase. © 2019 Deutsche Pharmazeutische Gesellschaft